HIV-1 infection in New York City STD clinic patients: evidence for stable seroprevalence, 1987-1988.

Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

HIV-1 infection in New York City STD clinic patients: evidence for stable seroprevalence, 1987-1988.

Int Conf AIDS. 1989 Jun 4-9;5:89 (abstract no. M.A.P.67). Unique Identifier : AIDSLINE ICA5/00022489
Weisfuse IB; Chiasson MA; Back S; Ramirez L; Greenberg B; Ewing W; New York City Department of Health, NY, NY. USA

Abstract: OBJECTIVE: To determine HIV-1 seroprevalence in patients at New York City STD clinics, and to compare rates over time in one clinic. METHODS: Blinded serosurveys were conducted among STD clinic patients in one clinic in 1987 and in all 12 STD clinics in 1988. The interval between the 2 surveys was 18 months. Specimens were obtained from routine syphilis testing and were analyzed for HIV-1 by ELISA with confirmatory Western Blot. Data on age, race/ethnicity, diagnosis and RPR result were collected. RESULTS: In 1988, 195/2533 (7.7%) of clinic attendees were HIV-1 positive. The highest rate (12.1%) was found among clinic attendees age 30-39. Among those diagnosed with a genital ulcer (GU) at the time of visit, 23/173 (13.3%) were HIV-1 positive as opposed 123/1782 (6.9%) with other diagnoses (p less than .05). For the clinic surveyed in both years, 26/348 (7.5%) were positive in 1987 and 34/694 (4.9%) positive in 1988. This difference was not statistically significant. In both 1987 and 1988 patients with GU were significantly more likely to be HIV-1 seropositive than were patients with other diagnoses, OR=2.3, p=.02 and OR=2.9, p=.04 respectively. CONCLUSIONS: HIV-1 is a common infection in New York City STD clinic patients and those with a GU are more likely to be infected. Seroprevalence remained constant in one STD clinic over an 18 month interval. The data support expanding the availability of HIV-1 counseling and testing in all STD clinics.

Keywords: Adult Ambulatory Care Facilities Female Genital Diseases, Female/COMPLICATIONS Genital Diseases, Male/COMPLICATIONS Human HIV Infections/COMPLICATIONS/*EPIDEMIOLOGY *HIV Seroprevalence HIV-1 Male New York City Sexually Transmitted Diseases/EPIDEMIOLOGY Ulcer/COMPLICATIONS ABSTRACT
900930
M9094767

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .